✦ LIBER ✦

Interaction between basic fibroblast growth factor and the anti-angiogenic drug PNU145156E

✍ Scribed by Moreno Zamai; Chithra Hariharan; Dina Pines; Michal Safran; Avner Yayon; Valeria R. Caiolfa; Mariangela Mariani; Ehud Pines; Rivka Cohen-Luria; Abraham H. Parola

Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 583 KB
Volume: 792-793
Category: Article
ISSN: 0022-2860
DOI: 10.1016/j.molstruc.2006.03.062

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ischemia increases the angiogenic potenc

Ischemia increases the angiogenic potency of basic fibroblast growth factor (FGF-2)

✍ Johannes Frank; Camilla M. A. Carroll; Karen Aaranson; Lazarre Ogden; Michael Ki 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB 👁 2 views

The aim of this study was to investigate the angiogenic response to exogenously administered basic fibroblast growth factor (FGF-2) in normal and ischemic skin, using the hairless mouse ear microcirculatory model. The hairless mouse ear is a well-established model for in vivo studies of skin microci

Ischemia increases the angiogenic potenc

Ischemia increases the angiogenic potency of basic fibroblast growth factor (FGF-2)

✍ Michael F. Angel 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 13 KB 👁 2 views

Interaction of heparin with human basic

Interaction of heparin with human basic fibroblast growth factor: Protection of the angiogenic protein from proteolytic degradation by a glycosaminoglycan

✍ Andreas Sommer; Daniel B. Rifkin 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 595 KB

Fibroblast growth factors (FGF) are a family of heparin-binding angiogenic polypeptide mitogens. In the presence of heparin, recombinant human basic fibroblast growth factor (bFGF) is fully protected from tryptic digestion and partially protected from chymotryptic digestion. Complete protection of b